ArticleEnvironmental science and pollution research international2025
Asphaltene-derived nanocomposites for the removal of emerging pollutants and its antimicrobial effects: batch and continuous column studies.
Article in Environmental science and pollution research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Emerging contaminants are diverse ecotoxic materials requiring unique treatment for removal. Asphaltenes are environmentally hazardous carbon-rich solid waste product of the petroleum industry. In the current work, asphaltene-derived activated carbon (AC) was loaded with silver (Ag/AC) and used to remove amoxicillin (AMX) and tetracycline (TC) from aqueous phase. The prepared Ag/AC was characterised using FESEM, FTIR, XRD and surface area analysis. The FESEM micrographs confirmed the spherical silver nanoparticle-laden porous AC, and the BET surface area was found to be 213 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.